SGO on the GO

Shannon Westin, MD, MPH interviews two speakers from the Presidential Symposium at ESMO 2026 on Saturday, October 24. (Lorusso) LBA11 - Sacituzumab Tirumotecan in Previously Treated Advanced or Recurrent Endometrial Cancer: Results from the Phase 3 TroFuse-005/ENGOT-en23/GOG-3095 Study(Slomovitz) LBA12 - KEYNOTE-C93/GOG-3064/ENGOT-en15: Phase 3, Randomized, Open-Label Study of First-Line (1L) Pembrolizumab (Pembro) vs Carboplatin (C) + Paclitaxel (P) in Mismatch Repair-Deficient (dMMR) ...

Shannon Westin, MD, MPH interviews some of the abstract presenters and discusses the abstract she presented during an exciting afternoon session on Day 2 of ESMO 2026, Saturday, October 24. (Backes) 1239O - NRG-GY020: Phase III Randomized Trial of Radiation +/- MK-3475 (Pembrolizumab) for Newly Diagnosed Early-Stage High Intermediate Risk (HIR) Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer(Westin) LBA37 - Durvalumab (D) plus carboplatin/paclitaxel (CP) followed by D w...

Shannon Westin, MD, MPH talks to a few of the abstract presenters from a Rapid Oral session on Day 2 of ESMO 2026, Saturday, October 24. (Meric-Bernstam) 1245RO - Updated results from FONTANA: Torvutatug samrotecan (torvu-sam), a folate receptor α (FRα)-targeted antibody-drug conjugate (ADC), in patients (pts) with platinum-resistant ovarian cancer (PROC)\(Salutari) LBA41 - Mocertatug rezetecan (Mo-Rez) in patients with platinum-resistant ovarian cancer (PROC): Updated results with long...

Shannon Westin, MD, MPH talks to Domenica Lorusso, MD, PhD and Fiona Simpkins, MD about the following abstracts presented in a Rapid Oral Session at ESMO 2026 on Friday, October 23. (Lorusso) 1241RO - Preliminary Efficacy of INCB123667 (CDK2 Inhibition) with Bevacizumab in Recurrent Epithelial Ovarian Cancer (rEOC)(Simpkins) 1242RO - Azenosertib in platinum-resistant ovarian cancer (PROC): overall survival analysis from Part 1b of the DENALI study (GOG-3066) Host: Shannon Westin, MD, M...

Clinical research is the backbone of advancing cancer care, and advanced practitioners are at the heart of it. This episode breaks down the fundamentals of clinical research, from study types and trial phases to key terms such as protocol, principal investigator, endpoints, informed consent, and hazard ratio. We explore common challenges in research participation, including patient hesitancy, mistrust, and complex protocols, and the unique and vital role APPs play in trial implementation: edu...